Plus Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
PSTV Nasdaq 8731 http://www.plustherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Plus Therapeutics Inc

Plus Therapeutics To Report Fourth Quarter and Full Fiscal Year 2019 Financial Results and Corporate Update on March 30, 2020 - Mar 25th, 2020 9:53 pm
Plus Therapeutics Welcomes Two New Directors - Mar 12th, 2020 11:15 am
Plus Therapeutics Appoints Chief Financial Officer - Feb 6th, 2020 10:00 pm
Plus Therapeutics Announces Changes to its Board of Directors - Feb 6th, 2020 10:00 pm
Plus Therapeutics Shareholder Update: Transition Achieved in 2019; Poised for Expansion in 2020 - Jan 6th, 2020 12:15 pm
Plus Therapeutics Appoints Dr. An van Es-Johansson to Board of Directors - Jan 2nd, 2020 9:15 pm
Plus Therapeutics to Present at Biotech Showcase 2020 - Dec 9th, 2019 12:00 pm
Plus Therapeutics to Present at the LD Micro Main Event (XII) - Nov 25th, 2019 12:00 pm
Plus Therapeutics Reports Third Quarter 2019 Financial and Business Results - Nov 14th, 2019 9:05 pm
Plus Therapeutics To Report Fiscal 2019 Third Quarter Financial Results and Corporate Update on November 14, 2019 - Nov 4th, 2019 12:00 pm
Plus Therapeutics Receives $4.6MM Reimbursement Payment - Oct 15th, 2019 1:20 pm
Plus Therapeutics, Inc. Announces Closing of $15 Million Underwritten Public Offering - Sep 26th, 2019 8:10 pm
Plus Therapeutics, Inc. Announces Pricing Of $15 Million Underwritten Public Offering - Sep 23rd, 2019 4:15 pm
Plus Therapeutics to Receive $4.6MM Reimbursement Payment - Sep 23rd, 2019 10:10 am